Enteric Hyperoxaluria After Gastric Bypass
The surgery that fixed his diabetes and his knees eight years ago is also the reason his kidneys are now forming stones — and that anatomy isn't something any of today's options can undo.
Victor S., a 55-year-old man, has coached his neighborhood's Little League team for the past nine summers, a commitment he only became physically able to keep up with after Roux-en-Y gastric bypass surgery eight years ago resolved both his type 2 diabetes and the knee pain that had kept him on the sidelines. He lost over a hundred pounds in the two years after surgery and has kept most of it off since. His second calcium oxalate stone in fourteen months passed on its own last week; a 24-hour urine collection done during his recovery from the first stone showed a urinary oxalate of 92mg/day, well above the roughly 40–45mg/day upper limit of normal, alongside a low urinary citrate and a generous urine volume that rules out simple dehydration as an explanation.
That pattern — markedly elevated oxalate with low citrate, in a patient years out from a malabsorptive bariatric procedure — is the signature of enteric hyperoxaluria, in which fat that isn't absorbed in the shortened intestine binds intestinal calcium as insoluble soaps instead of binding oxalate the way calcium normally would, leaving free oxalate to be absorbed and excreted through the kidneys instead. The anatomy that causes it is not something today's visit can change; the surgery that fixed his diabetes and his knees eight years ago is not going to be undone to fix his kidneys. Maalouf and colleagues measured the damage directly, comparing bypass patients one to seven years out against controls matched for body mass index: urinary oxalate 45 against 30mg/day, citrate 358 against 767. Victor is eight years out and sits at 92, roughly double the oxalate of the bypass patients in that comparison — and Maalouf's cohort were volunteers who had never formed a stone, while Victor has formed two in fourteen months. He is worse than the population that study used to establish the problem exists, which is the argument for treating him rather than watching him.
A related detail from the same comparison is worth naming directly rather than skating past: Maalouf's bypass patients ran a urinary calcium of 115mg/day against 196 in the BMI-matched controls, low enough that it partly offset their hyperoxaluria and left calcium-oxalate supersaturation only marginally higher between the groups. The likely reason is that the same intestinal fat-calcium binding at the heart of enteric hyperoxaluria that frees up oxalate also pulls filtered calcium down at the same time. That is part of why calcium supplementation is doing double duty here — binding dietary oxalate in the gut and correcting a calcium deficit that the surgery itself created — rather than treating two separate, unrelated problems.
In clinic, after his second oxalate stone
Calcium citrate taken with meals is the single most consistently supported intervention across the published series on exactly this population — it binds dietary oxalate in the gut before it can be absorbed, and case series show it correlates with lower urinary oxalate and lower supersaturation. I'd make that the anchor of his regimen.
I'd add dietary oxalate restriction alongside it, but I want to be honest about how thin the ground under it is. What we have in this population is observational, not a controlled trial of restriction, and Maalouf's own numbers are a caution against leaning on any single lever: his bypass patients were hyperoxaluric and hypocitraturic and still ended up with calcium-oxalate supersaturation only marginally above matched controls, because their urinary calcium had fallen too.
Supersaturation is the thing that precipitates stones, and it moves with several inputs at once. So diet is worth doing, but if we lean on it as the main lever instead of an adjunct to calcium and citrate, we're overstating what the evidence in this population actually supports.
Both of those work downstream of the actual cause. The whole cascade starts with unabsorbed fat binding his intestinal calcium as insoluble soaps, which is what frees the oxalate to be absorbed in the first place. A bile acid sequestrant reduces that free fatty acid pool directly — it's a step earlier than either calcium supplementation or dietary restriction, and I'd add it if his oxalate doesn't come down enough on the other two alone.
Agreed: calcium citrate with meals plus dietary counseling started today, with a repeat 24-hour urine collection in three months to see whether oxalate excretion has actually moved.
Also agreed: if it hasn't moved meaningfully, the bile acid sequestrant is the next step rather than simply intensifying the same two measures further.